phase readout

NCT06018337: A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)

ACTIVE_NOT_RECRUITINGupdated 1mo ago

community read0 votes

Sponsor: DualityBio Inc.. Phase: PHASE3. Conditions: Metastatic Breast Cancer

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

last refreshed 1h ago

Found something off?